Researchers Submit Patent Application, "Compositions And Methods For Treating Cancer", for Approval (USPTO 20240115727).

The patent application titled "Compositions And Methods For Treating Cancer" by Evan K. Day, Matthew J. Lazzara, and Benjamin Purow addresses the need for new approaches to target the Ras/ERK signaling pathway in cancer treatment. The application describes the use of vectors, fusion proteins, and peptide domains for gene therapy to treat cancer. It also mentions the use of a prodrug that can be converted into an active agent by the therapeutic polypeptide. The application provides detailed information about the specific nucleic acid sequences, polypeptides, and domains used in the invention, as well as kits and instructions for use. [Extracted from the article]